Disparities in use of lipid-lowering medications among people with type 2 diabetes mellitus Academic Article uri icon

Overview

MeSH Major

  • Anticholesteremic Agents
  • Cardiovascular Diseases
  • Diabetes Mellitus, Type 2

abstract

  • Veterans with diabetes but no recently coded heart disease, older individuals, and African Americans could benefit from programs targeted to introduce LLMs. Up to one third of individuals given LLMs remained above the target level of 130 mg/dL for low-density lipoprotein cholesterol.

publication date

  • May 28, 2003

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1001/archinte.163.8.922

PubMed ID

  • 12719201

Additional Document Info

start page

  • 922

end page

  • 8

volume

  • 163

number

  • 8